Eli Lilly announces new $4.5bn US site for manufacturing and drug development
Eli Lilly has announced that it is investing $4.5bn into a new US facility for advanced manufacturing and drug development. The Lilly Medicine Foundry will give the company the ability to research new ways of producing medicines, while also scaling up manufacturing of medicines for clinical trials, Lilly said.
Eli Lilly’s juggernaut diabetes and obesity drugs Mounjaro and Zepbound have been erased from the FDA’s shortage list, ...
The new funding will bring the Indianapolis-based drugmaker’s total investment in the Lebanon site to more than $13 billion, ...
Eli Lilly and Company (NYSE: LLY) today announced a $4.5 billion investment to create the Lilly Medicine Foundry, a new ...
Lilly officials on Wednesday said a newly-announced facility near Lebanon could shorten the drug research and development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback